Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study
- PMID: 26227434
- PMCID: PMC5714616
- DOI: 10.1016/S1474-4422(15)00132-5
Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study
Abstract
Background: A third of transient ischaemic attacks (TIAs) and ischaemic strokes are of undetermined cause (ie, cryptogenic), potentially undermining secondary prevention. If these events are due to occult atheroma, the risk-factor profile and coronary prognosis should resemble that of overt large artery events. If they have a cardioembolic cause, the risk of future cardioembolic events should be increased. We aimed to assess the burden, outcome, risk factors, and long-term prognosis of cryptogenic TIA and stroke.
Methods: In a population-based study in Oxfordshire, UK, among patients with a first TIA or ischaemic stroke from April 1, 2002, to March 31, 2014, we compared cryptogenic events versus other causative subtypes according to the TOAST classification. We compared markers of atherosclerosis (ie, risk factors, coronary and peripheral arterial disease, asymptomatic carotid stenosis, and 10-year risk of acute coronary events) and of cardioembolism (ie, risk of cardioembolic stroke, systemic emboli, and new atrial fibrillation [AF] during follow-up, and minor-risk echocardiographic abnormalities and subclinical paroxysmal AF at baseline in patients with index events between 2010 and 2014).
Findings: Among 2555 patients, 812 (32%) had cryptogenic events (incidence of cryptogenic stroke 0·36 per 1000 population per year, 95% CI 0·23-0·49). Death or dependency at 6 months was similar after cryptogenic stroke compared with non-cardioembolic stroke (23% vs 27% for large artery and small vessel subtypes combined; p=0·26) as was the 10-year risk of recurrence (32% vs 27%; p=0·91). However, the cryptogenic group had fewer atherosclerotic risk factors than the large artery disease (p<0·0001), small vessel disease (p=0·001), and cardioembolic (p=0·008) groups. Compared with patients with large artery events, those with cryptogenic events had less hypertension (adjusted odds ratio [OR] 0·41, 95% CI 0·30-0·56; p<0·0001), diabetes (0·62, 0·43-0·90; p=0·01), peripheral vascular disease (0·27, 0·17-0·45; p<0·0001), hypercholesterolaemia (0·53, 0·40-0·70; p<0·0001), and history of smoking (0·68, 0·51-0·92; p=0·01), and compared with small vessel and cardioembolic subtypes, they had no excess risk of asymptomatic carotid disease (adjusted OR 0·64, 95% CI 0·37-1·11; p=0·11) or acute coronary events (adjusted hazard ratio [HR] 0·76, 95% CI 0·49-1·18; p=0·22) during follow-up. Compared with large artery and small vessel subtypes combined, patients with cryptogenic events also had no excess of minor-risk echocardiographic abnormalities (cryptogenic 37% vs 45%; p=0·18) or paroxysmal AF (6% vs 10%; p=0·17) at baseline or of new AF (adjusted HR 1·23, 0·78-1·95; p=0·37) or presumed cardioembolic events (1·16, 0·62-2·17; p=0·64) during follow-up.
Interpretation: The clinical burden of cryptogenic TIA and stroke is substantial. Although stroke recurrence rates are comparable with other subtypes, cryptogenic events have the fewest atherosclerotic markers and no excess of cardioembolic markers.
Funding: Wellcome Trust, Wolfson Foundation, UK Stroke Association, British Heart Foundation, Dunhill Medical Trust, National Institute for Health Research, Medical Research Council, and the NIHR Oxford Biomedical Research Centre.
Copyright © 2015 Li et al. Open Access article distributed under the terms of CC BY-NC-ND. Published by Elsevier Ltd.. All rights reserved.
Figures
Comment in
-
Ischaemic stroke of undetermined cause.Lancet Neurol. 2015 Sep;14(9):871-872. doi: 10.1016/S1474-4422(15)00149-0. Epub 2015 Jul 27. Lancet Neurol. 2015. PMID: 26227433 No abstract available.
Similar articles
-
Diagnosis of non-consensus transient ischaemic attacks with focal, negative, and non-progressive symptoms: population-based validation by investigation and prognosis.Lancet. 2021 Mar 6;397(10277):902-912. doi: 10.1016/S0140-6736(20)31961-9. Lancet. 2021. PMID: 33676629 Free PMC article.
-
Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.Lancet Neurol. 2019 Mar;18(3):248-258. doi: 10.1016/S1474-4422(18)30442-3. Epub 2019 Feb 12. Lancet Neurol. 2019. PMID: 30784556 Free PMC article.
-
Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.Lancet Neurol. 2018 Jul;17(7):609-617. doi: 10.1016/S1474-4422(18)30167-4. Epub 2018 Jun 7. Lancet Neurol. 2018. PMID: 29887162 Free PMC article.
-
Long-term outcome after ischaemic stroke/transient ischaemic attack.Cerebrovasc Dis. 2003;16 Suppl 1:14-9. doi: 10.1159/000069936. Cerebrovasc Dis. 2003. PMID: 12698014 Review.
-
Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.Cochrane Database Syst Rev. 2015 Sep 8;2015(9):CD009938. doi: 10.1002/14651858.CD009938.pub2. Cochrane Database Syst Rev. 2015. PMID: 26346232 Free PMC article. Review.
Cited by
-
Occlusion of functional high-volume intra-atrial shunts in older patients after embolic stroke of undetermined source.Front Cardiovasc Med. 2024 Sep 27;11:1402137. doi: 10.3389/fcvm.2024.1402137. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39399510 Free PMC article.
-
Cardioembolic stroke in an HIV endemic region: underdiagnosed and severe.BMJ Neurol Open. 2024 Aug 1;6(2):e000592. doi: 10.1136/bmjno-2023-000592. eCollection 2024. BMJ Neurol Open. 2024. PMID: 39104634 Free PMC article.
-
Intersecting Pathways: The Role of Metabolic Dysregulation, Gastrointestinal Microbiome, and Inflammation in Acute Ischemic Stroke Pathogenesis and Outcomes.J Clin Med. 2024 Jul 21;13(14):4258. doi: 10.3390/jcm13144258. J Clin Med. 2024. PMID: 39064298 Free PMC article. Review.
-
Arterial Thrombosis in Patients with Cancer.Cancers (Basel). 2024 Jun 17;16(12):2238. doi: 10.3390/cancers16122238. Cancers (Basel). 2024. PMID: 38927943 Free PMC article. Review.
-
StrokeClassifier: ischemic stroke etiology classification by ensemble consensus modeling using electronic health records.NPJ Digit Med. 2024 May 17;7(1):130. doi: 10.1038/s41746-024-01120-w. NPJ Digit Med. 2024. PMID: 38760474 Free PMC article.
References
-
- Amarenco P. Cryptogenic stroke, aortic arch atheroma, patent foramen ovale, and the risk of stroke. Cerebrovasc Dis. 2005;20(suppl 2):68–74. - PubMed
-
- Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol. 2003;54:227–234. - PubMed
-
- Hart RG, Diener HC, Coutts SB. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13:429–438. - PubMed
-
- Ntaios G, Papavasileiou V, Milionis H. Embolic strokes of undetermined source in the athens stroke registry: a descriptive analysis. Stroke. 2015;46:176–181. - PubMed
-
- Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis. 2009;27:502–508. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
